Serenus Biotherapeutics is a privately held specialty biopharmaceutical company
Serenus Biotherapeutics is a privately held specialty biopharmaceutical company that specializes in late-stage drug development, in-licensing, registering, and commercializing therapies approved in the United States, Europe, and Japan to address unmet medical needs with high regional prevalence in the African market.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 3, 2015 | Series Unknown | $43M | 1 | Malin Corporation | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 12, 2022
Morpho Labs
|
Seed | $18M | Blockchain | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Malin Corporation | Yes | Series Unknown |